6915 Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
Am Surg. 2020 Dec;86(12):1691-1696. doi: 10.1177/0003134820945204. Epub 2020 Aug 27.
To assess if the choice of acetaminophen formulation (intravenous vs oral) when administered preoperatively for ambulatory cystoscopy procedures is associated with differences in anesthetic outcomes.
Medical records of adult patients undergoing ambulatory cystoscopy procedures at an outpatient procedural center from July 1, 2014, through November 30, 2017, were abstracted. The association between anesthetic outcomes (severe pain, rescue opioids, postoperative nausea, and vomiting) and acetaminophen formulation was assessed. Propensity-adjusted analyses were performed using inverse probability of treatment weighting to account for potential confounders.
During the study time frame, there were 611 intravenous and 2955 oral acetaminophen administrations for cystoscopy procedures. Postoperative bladder spasms were a major contributor to severe pain and complicated 1036 cases, with similar rates between intravenous (N = 183, 29.9%) and oral (N = 853, 28.9%) formulations, = .625. After adjusting for bladder spasms, intravenous acetaminophen was associated with longer anesthesia recovery (estimate 5.2 [95% CI 0.5-9.9] minutes, = .030), use of rescue opioids (odds ratio 1.33 [1.07-1.66], = .012), and postoperative nausea and vomiting (1.40 [1.02-1.93], = .037), but not severe pain (1.07 [0.81-1.40], = .640).
Preoperative intravenous acetaminophen compared to oral acetaminophen for ambulatory cystoscopy procedures was not associated with better anesthetic outcomes. Bladder spasms were a major contributor to postoperative pain.
评估在门诊膀胱镜检查程序中术前给予对乙酰氨基酚制剂(静脉与口服)的选择是否与麻醉结果的差异有关。
从 2014 年 7 月 1 日至 2017 年 11 月 30 日,摘录在门诊程序中心接受门诊膀胱镜检查程序的成年患者的病历。评估麻醉结果(严重疼痛、解救阿片类药物、术后恶心和呕吐)与对乙酰氨基酚制剂之间的关联。使用逆概率治疗加权法进行倾向调整分析,以考虑潜在的混杂因素。
在研究时间段内,有 611 例静脉和 2955 例口服对乙酰氨基酚用于膀胱镜检查程序。术后膀胱痉挛是严重疼痛的主要原因,共 1036 例,静脉(N=183,29.9%)和口服(N=853,28.9%)制剂之间的发生率相似, =.625。在调整膀胱痉挛后,静脉内对乙酰氨基酚与麻醉恢复时间延长相关(估计值为 5.2 [95%CI 0.5-9.9] 分钟, =.030)、使用解救阿片类药物(比值比 1.33 [1.07-1.66], =.012)和术后恶心和呕吐(1.40 [1.02-1.93], =.037)相关,但与严重疼痛(1.07 [0.81-1.40], =.640)无关。
与口服对乙酰氨基酚相比,门诊膀胱镜检查程序中术前静脉内给予对乙酰氨基酚与麻醉结果无显著差异。膀胱痉挛是术后疼痛的主要原因。